Main Catalog

Found 70
Sort by
Home Study Programs
Member Free
Non-Member $30.00

AMCP Federal and State Legislative/Regulatory Update Home Study

Contact Hours: 1.0. In today’s world, healthcare legislation and regulation move at a staggering pace making it difficult for health professionals to keep up.
Law
AMCP Annual Meeting
Member Free
Non-Member $30.00

AMCP Headline Session: 2017–2018 Pharmaceutical Marketplace Trends

Not Accredited for CPE: Keeping abreast of industry trends and forecasts is vital to remaining competitive in the evolving managed care arena— especially because market predictions can shape the approach to managing the pharmacy benefit.
AMCP Headline Session 2018
Nexus Conferences
Member Free
Non-Member $30.00

Best Practices in Combating Opioid Abuse, Misuse and Diversion: The Health Plan Perspective - Nexus 2017

Contact Hours: 1.5. The opioid epidemic in the United States continues to worsen. Roughly 91 Americans die each day from an opioid overdose.
Opioid
AMCP Annual Meeting
Member Free
Non-Member $30.00

Best Practices to Implementing Proactive Communications Between Manufacturers and Payers

Contact Hours: 1.25. The recent enactment of the 21st Century Cures Act, and specifically Section 3037 (Cures 3037), modernized provisions of the Food and Drug Administration Modernization Act of 1997, Section 114 (FDAMA 114).
Managed Care Regulation
Nexus Conferences
Member Free
Non-Member $30.00

Biosimilars in the United States: Barriers, Solutions, Real-World Evidence, and the Experience of One Health System

Contact Hours: 1.5. As of July 2019, the U.S. Food and Drug Administration (FDA) had approved 25 biosimilar or follow-on biologic products.
Biosimilars
Nexus Conferences
Member Free
Non-Member $30.00

Bracing for Impact: Preparing for the 2019 Specialty Drug Spend - Nexus 2017

Contact Hours: 1.5. The escalating cost of prescription drugs is an issue that continues to plague the U.S. health care system, accounting for 17% of the total health care spend in 2015.
Hospital/Health Systems
AMCP Annual Meeting
Member Free
Non-Member $30.00

Brand and Generic Drugs in Development

Contact Hours: 1.25. This session focuses on new and emerging brand-name drugs, as well as upcoming generic drug approvals.
Brand and Generic Drugs
Nexus Conferences
Member Free
Non-Member $30.00

Budget Impact Models: How Payers Can Build and Validate - Nexus 2017

Contact Hours: 1.5. Budget impact models (BIMs) can be built and used by payers for many decisions, including changes to the formulary.
Hospital/Health Systems
Nexus Conferences
Member $15.00
Non-Member $30.00

Checking In on Health Care Reform Efforts: What Do They Mean for Payers, Manufacturers and Patients?

Contact Hours: 1.5. While broader drug pricing reform efforts have taken the lion’s share of attention in health policy discourse over the past year, the Trump Administration has continued to move forward with implementing changes to the Affordable Care Act (ACA).
Health Care Reform HCA
Nexus Conferences
Member Free
Non-Member $30.00

Coverage and Reimbursement for High Cost Curative Therapeutics: Does a Solution Exist? - Nexus 2018

Contact Hours: 1.5. More and more, managed care organizations are straddling the line between making new, innovative therapies available to their patients and ensuring they can cover the costs of these therapies.
Drug Pricing
AMCP Annual Meeting
Member $15.00
Non-Member $30.00

Developments, Research, Pipeline, and Applications of Gene Therapy - Annual 2019

Contact Hours: 0.75: Gene therapy is a promising treatment option for a number of diseases, including inherited disorders, some types of cancer, and certain viral infections. The first gene therapy approvals in the United States occurred in 2017.
Gene Therapy
Nexus Conferences
Member Free
Non-Member $30.00

End of an Era: Lessons Learned from 2018 CMS Audits, and Prep for the Future - Nexus 2018

Contact Hours: 1.5. Ready for that upcoming 2019 audit? Do you know how to prepare? If your answer is no, join this session to hear how health plans prepare for their audits and address corrective actions, as lessons learned from the 2018 audit season are discussed.
CMS
Nexus Conferences
Member Free
Non-Member Free

Expanding the Managed Care Professional’s Digital Therapeutics IQ - Home Study

Contact Hours: 1.5. Digital therapeutics are expanding the boundaries of the types of therapies that health care decision-makers must be adept at evaluating.
Digital Health
Nexus Conferences
Member Free
Non-Member $30.00

Experience and Lessons Learned in Biosimilar Uptake - Nexus 2018

Contact Hours: 1.5. Although biosimilars have been on the market for some time, payers continue to face many challenges in implementation.
Biosimilars
Nexus Conferences
Member $15.00
Non-Member $30.00

Fast and Furious: What is Driving the Specialty Spend?

Contact Hours: 1.5. In 2018, the United States spent an estimated $517 million on specialty drugs. While specialty medications make up only about 1–2 % of all prescriptions written, they account for nearly 50% of total drug spend.
Specialty Drug Spend
AMCP Annual Meeting
Member Free
Non-Member $30.00

Federal and State Legislative and Regulatory Update - Annual Meeting 2018

Contact Hours: 1.25. This must-attend session will bring you timely updates on the latest federal and state legislative and regulatory actions of interest to pharmacists and other managed care and specialty pharmacy professionals.
Law
AMCP Annual Meeting
Member Free
Non-Member $30.00

Federal and State Legislative and Regulatory Update - Annual Meeting 2019

Contact Hours: 1.25. This must-attend session will bring you timely updates on the latest federal and state legislative and regulatory actions of interest to managed care and specialty pharmacy professionals.
Law
Nexus Conferences
Member Free
Non-Member $30.00

Federal and State Legislative and Regulatory Update - Nexus 2017

Contact Hours: 1.5. This must-attend session will bring you timely updates on the latest federal and state legislative and regulatory actions of interest to managed care and specialty pharmacy professionals.
Law
Nexus Conferences
Member Free
Non-Member $30.00

Federal and State Legislative and Regulatory Update - Nexus 2018

Contact Hours: 1.5. This must-attend session will bring you timely updates on the latest federal and state legislative and regulatory actions of interest to managed care and specialty pharmacy professionals.
Law
AMCP Annual Meeting
Member $15.00
Non-Member $30.00

Financial Models to Manage Drug Spend of Gene Therapy - Annual Meeting 2019

Contact Hours 1.0: Gene therapy techniques offer potential breakthroughs for patients with serious health conditions. They also are associated with significant short-term costs yet hold the promise of long-term savings.
Gene Therapy
Certificate Programs
Member $399.00
Non-Member $499.00

Fundamentals of Managed Care Pharmacy Certificate Program 2nd Edition - Professional Version

Contact Hours: 8.75 (0.875 CEUs). The Fundamentals of Managed Care Pharmacy Certificate Program provides a comprehensive introduction to basic concepts in managed care pharmacy.
Fundamentals of Managed Care Pharmacy
Certificate Programs
Member $199.00
Non-Member $249.00

Fundamentals of Managed Care Pharmacy Certificate Program 2nd Edition | Student Version

The Fundamentals of Managed Care Pharmacy Certificate Program provides a comprehensive introduction to basic concepts in managed care pharmacy.
Fundamentals of Managed Care Pharmacy
Nexus Conferences
Member $15.00
Non-Member $30.00

How Continued Drug Shortages Compromise Patient Care

Contact Hours: 1.5. Providing safe and effective drug therapy has become extremely challenging during extended periods of drug shortages.
Drug Shortages
Nexus Conferences
Member Free
Non-Member $30.00

Improving Star Ratings Through Focused Clinical Strategy and Targeted Outreach: Results from a Systematic Approach - Nexus 2018

Contact Hours: 1.5. Star Ratings continue to evolve as measure specifications, benchmarks and inclusion into the overall calculation continue to change under Medicare.
CMS
Nexus Conferences
Member $15.00
Non-Member $30.00

Increasing Positive Outcomes: The Impact of Social Determinants of Health

Contact Hours: 1.5. There is a growing body of evidence that highlights how social determinants of health—socioeconomic status, education, physical environment, employment, and social support networks—play a large role in determining overall health outcomes.
Social Determinants